Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiahua Pan

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Circulation|October 13, 2025
Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical TrialFengwen Zhang, Jie Dong, Peijian Wei, et al.
Journal of Cancer|December 1, 2017
Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate CancerYanqing Wang, Wei Chen, Chuanyi Hu, et al.
Nature Communications|March 23, 2021
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesisXun Shangguan, Jianli He, Zehua Ma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2021
Use of Circulating Tumor DNA for the Clinical Management of Metastatic Castration-Resistant Prostate Cancer: A Multicenter, Real-World StudyBaijun Dong, Liancheng Fan, Bin Yang, et al.
The Prostate|August 15, 2017
Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancerBaijun Dong, Liancheng Fan, Yanqing Wang, et al.
Translational Oncology|May 29, 2023
Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancerXinxing Du, Xiaochen Fei, Jialin Wang, et al.
The Prostate|July 29, 2017
Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abirateroneLiancheng Fan, Xiao Wang, Chenfei Chi, et al.
Cell Death & Disease|August 12, 2025
Lnk deficiency attenuates the immunosuppressive capacity of MDSCs via ferroptosis to suppress tumor developmentJingwen Zhou, Hui Yin, JiaHua Pan, et al.
Molecular Medicine (Cambridge, Mass.)|July 3, 2026
Low-PSMA hormone-sensitive prostate cancer: a distinct clinical and molecular stateHaotian Wu, Ang Li, Zhou Jiang, et al.
Journal of Cancer|November 21, 2017
Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With AbirateroneLiancheng Fan, Chenfei Chi, Sanwei Guo, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Circulation|October 13, 2025
Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical TrialFengwen Zhang, Jie Dong, Peijian Wei, et al.
Journal of Cancer|December 1, 2017
Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate CancerYanqing Wang, Wei Chen, Chuanyi Hu, et al.
Nature Communications|March 23, 2021
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesisXun Shangguan, Jianli He, Zehua Ma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2021
Use of Circulating Tumor DNA for the Clinical Management of Metastatic Castration-Resistant Prostate Cancer: A Multicenter, Real-World StudyBaijun Dong, Liancheng Fan, Bin Yang, et al.
The Prostate|August 15, 2017
Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancerBaijun Dong, Liancheng Fan, Yanqing Wang, et al.
Translational Oncology|May 29, 2023
Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancerXinxing Du, Xiaochen Fei, Jialin Wang, et al.
The Prostate|July 29, 2017
Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abirateroneLiancheng Fan, Xiao Wang, Chenfei Chi, et al.
Cell Death & Disease|August 12, 2025
Lnk deficiency attenuates the immunosuppressive capacity of MDSCs via ferroptosis to suppress tumor developmentJingwen Zhou, Hui Yin, JiaHua Pan, et al.
Molecular Medicine (Cambridge, Mass.)|July 3, 2026
Low-PSMA hormone-sensitive prostate cancer: a distinct clinical and molecular stateHaotian Wu, Ang Li, Zhou Jiang, et al.
Journal of Cancer|November 21, 2017
Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With AbirateroneLiancheng Fan, Chenfei Chi, Sanwei Guo, et al.
Pageof 15